Standard Bariatrics
Acquired11 known investors
Standard Bariatrics develops the Titan SGS™ Stapler, a specialized surgical device designed for sleeve gastrectomy procedures that creates consistent and symmetrical gastric pouches using an anatomy-based approach.
Also known as Standard Bariatrics, Inc.
Investors · 11
Also in the syndicate · 4
Company profile
researched Aug 2026Standard Bariatrics, Inc. is a surgical procedure company that develops and commercializes medical devices for bariatric surgery, originally based in Cincinnati, Ohio. Its core product is the Titan SGS stapler, a linear cutter designed specifically for longitudinal transection and resection of gastric tissue in sleeve gastrectomy pouch creation. The device offers a 23-centimeter continuous staple cutline, described as the industry's longest, and is presented as the only commercially available stapler in the United States with a specific indication for gastric sleeve pouch creation. The stapler received FDA 510(k) clearance (K210278) in April 2021, supported by a 62-patient study, and was first used clinically in August 2021.
The product line has expanded into a portfolio marketed around the Titan Sleeve technique, an anatomy-based approach intended to produce a symmetrical, standardized sleeve pouch. Portfolio components include the Titan SGS stapler, a power unit, staple line reinforcement, a precision bougie and a trocar device. Technical features cited by the company include graduated staple height formation, load-sensing technology, real-time feedback and a firing cycle optimized for gastric tissue, with a single firing used to complete the sleeve pouch.
The company was acquired by Teleflex Incorporated under a definitive agreement announced in August 2022, and its products are now marketed under Teleflex, which holds the Standard Bariatrics, Titan SGS and Titan Sleeve trademarks.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 1
by search overlapCompanies competing with Standard Bariatrics for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 11
launches, deals, and filingsMoataz Bashah completed the first series of sleeve gastrectomies using the Titan SGS 23 cm linear stapler outside the United States, in Doha, Qatar, in partnership with Al-Danah Medical Co. W.L.L.
Teleflex announced a supply agreement with W. L. Gore & Associates to use Gore's GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement material in a staple line reinforcement device designed for use with the Titan SGS powered stapling system.
A group purchasing organization agreement with Premier, Inc. for the Titan SGS powered stapling device expanded access for surgeons affiliated with Premier.
Standard Bariatrics, Inc. signed a definitive agreement to be acquired by Teleflex Incorporated (NYSE: TFX), subject to customary closing conditions.
Standard Bariatrics closed a debt facility with Silicon Valley Bank providing $7 million in term loans, of which the first $4 million was funded at closing, to accelerate commercial efforts for the Titan SGS stapler and related devices. Announced May 9, 2022.
$7M source ↗
The company announced completion of its $35 million Series B ahead of schedule, receiving the remaining $9 million after the Titan SGS launch completed the milestones for the second tranche.
$9M source ↗
Following FDA clearance, the Titan SGS surgical stapler was first used clinically in August 2021.
Completion of a $35 million Series B round led by U.S. Venture Partners, with new investor River Cities Capital and Series A syndicate investors participating, announced immediately following FDA clearance.
$35M source ↗
The Titan SGS stapler received FDA clearance (510(k) K210278, published April 28, 2021) for longitudinal transection and resection of gastric tissue for sleeve gastrectomy pouch creation, supported by a 62-patient study.
Standard Bariatrics raised an undisclosed Series A round led by RiverVest Venture Partners, with participation from Hatteras Venture Partners, Queen City Angels/QCA First Fund V, Emergent Medical Partners, Accelerant Fund and North Coast Angels, to complete product development for gastric procedure products.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Standard Bariatricsstandardbariatrics.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Standard Bariatrics do?
- Cincinnati-based maker of the Titan SGS powered surgical stapler for sleeve gastrectomy, acquired by Teleflex in 2022.
- Who are Standard Bariatrics's investors?
- Standard Bariatrics's investors include CincyTech, Emergent Medical Partners, LLP, Hatteras Venture Partners, JobsOhio Ventures, RC Capital, RiverVest Venture Partners, US Venture Partners.